NHS calls for more investment in specialist diabetes care

by PharmaTimes | 1st Jan 2000 | News

Tags

Related posts

Bioxytran reports rapid viral clearance in phase 2 trial

Bioxytran reports rapid viral clearance in phase 2 trial

Feb 11, 2026

Thx Pharma and Biocodex sign rare disease licensing deal

Thx Pharma and Biocodex sign rare disease licensing deal

Feb 11, 2026

AstraZeneca bladder cancer therapy wins NICE backing

AstraZeneca bladder cancer therapy wins NICE backing

Feb 10, 2026

Redefining trial access

Redefining trial access

Feb 10, 2026

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN

E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999